Abstract

The selectivity of electrochemical sensors to ascorbic acid (AA), dopamine (DA), and uric acid (UA) remains an open challenge in the field of biosensing. In this study, the selective mechanisms for detecting AA, DA, and UA molecules on the graphene and graphene oxide substrates were illustrated through the charge population analysis from the density functional theory (DFT) calculation results. Our substrate models contained the 1:10 oxygen per carbon ratio of reduced graphene oxide, and the functionalized configurations were selected according to the formation energy. Geometry optimizations were performed for the AA, DA, and UA on the pristine graphene, epoxy-functionalized graphene, and hydroxyl-functionalized graphene at the DFT level with vdW-DF2 corrections. From the calculations, AA was bound to both epoxy and hydroxyl-functionalized GO with relatively low adsorption energy, while DA was adsorbed stronger to the electronegative epoxy groups. The strongest adsorption of UA to both functional groups corresponded to the largest amount of electron transfer through the pi orbitals. Local electron loss created local electric fields that opposed the electron transfer during an oxidation reaction. Our analysis agreed with the results from previous experimental studies and provided insight into other electrode modifications for electrochemical sensing.

Highlights

  • One of the open problems in the field of biosensing is the simultaneous detection of ascorbic acid (AA), dopamine (DA), and uric acid (UA) within body fluids

  • Similar trends were observed from previous density functional theory (DFT) studies that the graphene oxide (GO) structures with clustered functional groups were more stable than the GO structures with isolated functional groups [41,42]

  • The mechanisms of oxidation potential shift of AA, DA, and DA molecules on the GO or reduced graphene oxide (rGO) surfaces were illustrated through changes in the charge distribution within the analyte molecules at different oxidation and binding states

Read more

Summary

Introduction

One of the open problems in the field of biosensing is the simultaneous detection of ascorbic acid (AA), dopamine (DA), and uric acid (UA) within body fluids. The concentration of DA in human serum is linked to the mental status of the patient [4], which might further cause uncertainty and false-positive detections of AA and UA [5]. To overcome this problem from the CV peak overlapping, modification of the electrode is necessary

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call